Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Earlier use of budesonide lowers asthma-related events in children, study shows
April 28th, 2005
New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication. The findings, presented at the 61st annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI), are from 2 analyses of the Inhaled Steroid as Regular Therapy in Early Asthma (START) study, a 3-year trial involving nearly 2,000 children ages 5 to 10 years with mild persistent asthma. The START study was funded by AstraZeneca (AZN). ...
Source: Women's Health Weekly (2005-04-28)
|
